PCN272 OBINUTUZUMAB TREATMENT ON 1ST LINE HIGH AND INTERMEDIATE RISK FOLLICULAR LYMPHOMA. SHORT-TERM REDUCTION OF RELAPSED OR REFRACTORY DIRECT MEDICAL COSTS IN ARGENTINA AND CHILE.
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.467
https://www.valueinhealthjournal.com/article/S1098-3015(19)32845-1/fulltext
Title :
PCN272 OBINUTUZUMAB TREATMENT ON 1ST LINE HIGH AND INTERMEDIATE RISK FOLLICULAR LYMPHOMA. SHORT-TERM REDUCTION OF RELAPSED OR REFRACTORY DIRECT MEDICAL COSTS IN ARGENTINA AND CHILE.
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32845-1&doi=10.1016/j.jval.2019.09.467
First page :
Section Title :
Open access? :
No
Section Order :
10388